Central and peripheral neurologic manifestations of critical medical illness

CONTINUUM Lifelong Learning in Neurology

Volumn 14, Issue 1, 2008, Pages 74-93

  Khan, Jaffar ^a   Harrison, Taylor ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; DEXMEDETOMIDINE; DIAZEPAM; DIGITALIS; DROTRECOGIN; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; OPIATE ANTAGONIST; OPIATE DERIVATIVE; PARACETAMOL; PENICILLIN DERIVATIVE; PHENOTHIAZINE DERIVATIVE; PROPOFOL; QUINOLONE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; STEROID; SULFONAMIDE; TACROLIMUS; UNINDEXED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; BLEEDING; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMA; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL ILLNESS; DELIRIUM; ELECTROENCEPHALOGRAM; HUMAN; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNIT; MORBIDITY; MULTIPLE ORGAN FAILURE; MYOPATHY; NEUROLOGIC DISEASE; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; REVIEW; SEIZURE; SEPSIS; SEPTIC SHOCK; SLEEP WAKING CYCLE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEAKNESS;

EID: 40049098119     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000299987.78952.3d     Document Type: Review

References (50)

1. Abou Khaled KJ, Hirsh LJ. Advances in the management of seizures and status epilepticus in critically ill patients. Crit Care Clin 2006;22(4):637-659; abstract viii.
2. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005;353(13):1332-1341. A seminal study for the use of activated protein C to improve mortality in severe sepsis.
3. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29(7):1303-1310. A widely cited study of the epidemiology of severe sepsis.
4. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344(10):699-709.
5. Bleck TP, Smith MC, Pierre-Louis SJ, et al. Neurologic complications of critical medical illnesses. Crit Care Med 1993;21(1):98-103. A prospective study describing the frequency with which unselected subjects in the intensive care unit (ICU) experience neurologic complications associated with systemic illness.
6. Bolton CF. AAEM minimonograph #40: clinical neurophysiology of the respiratory system. Muscle Nerve 1993;16(8):809-818. This is an excellent review of the neurophysiology of the phrenic nerve and diaphragm.
7. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005;32(2):140-163. Comprehensive review of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM).
8. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47(11):1223-1231. Original clinical and electrophysiologic description of CIP.
9. Bolton CF, Laverty DA, Brown JD, et al. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1986;49(5):563-573.
10. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101(6):1644-1655. Describes current consensus guidelines for the diagnosis of systemic inflammatory response and sepsis syndromes.
11. Brust JCM. Neurotoxic side effects of prescription drugs. Boston: Butterworth-Heinemann, 1996:313-316.
12. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993;19(6):323-328.
13. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14(11):1131-1139. Describes the histopathology of muscle in CIM.
14. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004a;291(14):1753-1762. A prospective single-center cohort study in an academic center reporting that delirium is an independent risk factor for 6-month mortality and longer hospital stay.
15. Ely EW, Stephens RK, Jackson JC, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004b;32(1):106-112.
16. Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003;31(4):1012-1016. Describes clinical and neurophysiologic findings in survivors of critical illness.
17. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348(8):683-693. Identifies neuromuscular weakness as a factor in the reduced health-related quality of life of acute respiratory distress syndrome survivors.
18. Hirano M, Ott BR, Raps EC, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992;42(11):2082-2087. Clinical, electrophysiologic, and histopathologic description of CIM.
19. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340(9):669-676.
20. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275(11):852-857.
21. Jackson AC, Gilbert JJ, Young GB, Bolton CF. The encephalopathy of sepsis. Can J Neurol Sci 1985;12(4):303-307. A retrospective case series of 12 fatal cases of sepsis-associated encephalopathy suggesting a role for direct microbial invasion of the CNS: disseminated cerebral micro-abscesses were reported in 8 of 12 subjects.
22. Jackson WL Jr, Shorr AF. The yield of lumbar puncture to exclude nosocomial meningitis as aetiology for mental status changes in the medical intensive care unit. Anaesth Intensive Care 2006;34(1):21-24. A retrospective single-center study suggesting that lumbar puncture for the diagnosis of nosocomial meningitis is of low yield in a population of critically ill subjects without immunodeficiency, traumatic head injury, or recent neurosurgical intervention.
23. Joint Commission on Accreditation of Healthcare Organizations (JCAHO). The specifications manual for national hospital quality measures-ICU. http://www.jointcommission.org/PerformanceMeasurement/MeasureReserveLibrary/ Spec+Manual+-+ICU.htm. Published 2005. Accessed September 11, 2007.
24. Kelly BJ, Matthay MA. Prevalence and severity of neurologic dysfunction in critically ill patients. Influence on need for continued mechanical ventilation. Chest 1993;104(6):1818-1824. A prospective single-center study in the tertiary critical care setting reporting both a high frequency of neurologic dysfunction and its adverse impact on duration of mechanical ventilation.
25. Khan J, Burnham EL, Moss M. Acquired weakness in the ICU: critical illness myopathy and polyneuropathy. Minerva Anestesiol 2006a:72(6):401-406.
26. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006b;67(8):1421-1425. Notes that electrophysiologic abnormalities occur early in critical illness and that CIP and CIM coexist in patients with critical illness.
27. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40(4):645-654.
28. Lacomis D, Petrella JT, Guiliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998;21(5):610-617. Notes that CIM may be more common than CIP.
29. Larsson L, Li X, Edström L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 2000;28(1):34-45. Describes pathologic findings in CIM.
30. Latronico N, Fenzi F, Recupero D, et al. Critical illness myopathy and neuropathy. Lancet 1996;347(9015):1579-1582. Describes clinical, electrophysiologic, and pathologic aspects of neuromuscular disease acquired during critical illness.
31. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;2(8038):615. Original description of CIM.
32. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995;273(4):306-309.
33. Miniño AM, Heron MP, Smith BL. Deaths: preliminary data for 2004. Natl Vital Stat Rep 2006;54(19):1-49. Reports that, as of 2004, sepsis is the 10th leading cause of death.
34. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30(1):142-156.
35. Peterson JF, Pun BT, Dittus RS, et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006;54(3):479-484. A prospective tertiary care cohort study reporting a high frequency of delirium among ICU subjects, highlighting the impact of older age (greater than 65) on both the frequency of delirium and the hypoactive delirium subtype, which may be overlooked.
36. Plum F, Posner JB. The diagnosis of stupor and coma. 3rd ed. Philadelphia: FA Davis Co., 1980. The classic reference on disorders of consciousness, it remains a necessary text for any neurologist's library.
37. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273(2):117-123.
38. Rich MM, Bird SJ, Raps EC, et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20(6):665-673. Applies direct muscle stimulation to the evaluation of weakness acquired in the ICU.
39. Rich MM, Teener JW, Raps EC, et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46(3):731-736. Offers electrical inexcitability of muscle as an explanation of weakness in CIM.
40. Schwarz J, Planck J, Briegel J, Straube A. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 1997;20(6):696-701. Describes the histopathology of CIP.
41. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20(3):316-322. Describes pathologic findings in CIM.
42. Tirschwell DL. Critical care neurology. Coma in the intensive care unit: predicting awakening following cardiac and respiratory arrest. Continuum: Lifelong Learning Neurol 2006;12(1):46-69. A comprehensive review of predictors for clinical recovery after cardiopulmonary arrest.
43. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54(2):340-345. A widely cited prospective study reporting that 8% of comatose subjects without clinical findings suggestive for seizure activity were in nonconvulsive status epilepticus.
44. Udobi KF, Childs E, Touijer K. Sepsis/Acute respiratory distress syndrome. Clin Fam Prac 2004;6(1):101-126.
45. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345(19):1359-1367. Strict glucose control may decrease mortality; these authors additionally suggest that neurologic morbidity may also be impacted by decreasing the incidence of CIP.
46. Wijdicks EF, Scott JP. Stroke in the medical intensive-care unit. Mayo Clin Proc 1998;73(7):642-646. A single-center retrospective study reporting high mortality of patients suffering stroke in the setting of critical illness, highlighting the importance of disseminated intravascular coagulation.
47. Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology 1993;43(5):1042-1044.
48. Wijdicks EF, Stevens M. The role of hypotension in septic encephalopathy following surgical procedures. Arch Neurol 1992;49(6):653-656. A retrospective study that posits that hypotension underlies sepsis-associated encephalopathy.
49. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99(1):176-184. Describes the prognosis of patients with CIP.
50. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110(pt 4):819-841. Establishes an association between CIP and severe sepsis.